Trial Profile
Randomized study of high-dose chemotherapy plus rituximab (R-HDS) vs conventional chemotherapy with rituximab (R-FC) in chronic lymphocytic leukemia at high risk.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Antineoplastics; Cyclophosphamide; Fludarabine
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 25 May 2011 New trial record